Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

Figure 2

Follow-up and study visits. Study visits will be performed in 3-months intervals within the first 18 months and in 6-months intervals thereafter. Total follow-up will be 24 months after end-of-recruitment or 36–72 months after randomization.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us